Dronedarone

Drug Profile

Dronedarone

Alternative Names: Drondarone; Multag; Multaq; SB-33589; SR 33589; SR 33589B

Latest Information Update: 24 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator sanofi-aventis
  • Developer Sanofi
  • Class Benzofurans; Class III antiarrhythmics; Ischaemic heart disorder therapies; Small molecules
  • Mechanism of Action Calcium channel antagonists; Potassium channel antagonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Atrial fibrillation; Atrial flutter

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Atrial-fibrillation(Combination therapy, In volunteers) in France (PO, Tablet)
  • 10 May 2017 Launched for Atrial fibrillation in Greece, Hungary, Australia and China (PO) before May 2017
  • 11 Jul 2011 European Medicines Agency broadens ongoing benefit-risk assessment of dronedarone to include review of cardiovascular risk
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top